World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Lifestyle

MEDICAL CANNABIS CONSORTIUM LAUNCHES FIRST MULTI-CLINIC PATIENT SURVEY OF ITS KIND

Cision PR Newswire by Cision PR Newswire
May 22, 2026
in Press Releases - Lifestyle
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Landmark Insights Reveal 97.6% Of Mental Health Patients Reported Symptom Improvement, With 88.3% Rating It Their Most Effective Treatment Pathway To Date

  • More than 6,000 patients across four of the UK’s largest medical cannabis clinics participated in the survey, including 5,128 patients prescribed treatment for anxiety, depression or post-traumatic stress disorder
  • 97.6% reported improvement in symptoms
  • 92.3% reported improvement in sleep
  • 93.5% reported improvement in ability to function day to day
  • 90.7% said medical cannabis was more effective than previous treatments tried
  • 88.3% said it was the most effective treatment they had tried

LONDON, May 22, 2026 /PRNewswire/ — A new multi-clinic patient survey spanning four of the UK’s leading medical cannabis providers, Mamedica, Alternaleaf, CB1 Medical and Curaleaf, has revealed findings from the largest pooled UK patient survey of its kind to date on patients prescribed medical cannabis for anxiety, depression and post-traumatic stress disorder (PTSD).

The survey gathered responses from 6,282 patients in total, including a 5,128-patient sub-cohort prescribed treatment for anxiety, depression or PTSD, reflecting a population with long-term and often complex clinical needs. Among this group, 97.6% reported improvement in symptoms, 92.3% reported improved sleep, and 93.5% reported improved day-to-day functioning. A further 90.7% said medical cannabis was more effective than previous treatments they had tried, while 88.3% described it as the most effective treatment pathway they had used.

The findings come amid sustained pressure on UK mental health services, with more than four million people in contact with NHS mental health, learning disability and autism services in 2024/25. Published estimates from the STAR*D trial and subsequent analyses suggest around 30% of patients with major depression do not achieve adequate symptom relief after multiple treatment attempts.

While the clinics stress that these cross-sectional, voluntary patient survey findings should not be interpreted as definitive evidence of efficacy, they add to a growing body of real-world evidence, including the UK Medical Cannabis Registry and Project Twenty21, supporting considered prescribing in patients who have not benefited from first-line interventions.

In the UK, medical cannabis can only be prescribed by doctors listed on the GMC Specialist Register under Care Quality Commission-regulated clinical frameworks. The consortium said this is the first time multiple UK medical cannabis clinics have pooled patient experience data at this scale, with plans to repeat the survey annually and support further research into treatment-resistant mental health conditions.

Website: www.mamedica.co.uk

Cision View original content:https://www.prnewswire.co.uk/news-releases/medical-cannabis-consortium-launches-first-multi-clinic-patient-survey-of-its-kind-302780415.html

Cision PR Newswire

Cision PR Newswire

Related Posts

The One Where SHEGLAM Meets FRIENDS

October 26, 2026

Rapidus and HCLTech announce partnership for next-generation semiconductor technologies

October 26, 2026

Parloa’s Agent Management Platform now sold as an SAP Solution Extension for agentic customer interactions

October 26, 2026

Temu Partners with Spain’s Recyclia to Support Seller Extended Producer Responsibility

October 26, 2026

SUNON Brings AI, Nature and Human-Centered Design to ORGATEC 2026

October 26, 2026

Innovent Announces NMPA Acceptance of a New Indication Application of Sintilimab for the Treatment of Advanced Melanoma

October 26, 2026

Popular News

  • YeahPay targets the trust gap holding back autonomous AI shopping

    0 shares
    Share 0 Tweet 0
  • Thunes and PayerMax Deepen Strategic Collaboration to Enhance Global Payout Capabilities

    0 shares
    Share 0 Tweet 0
  • Linux Foundation Announces the Open Financial Trust Alliance to Strengthen Coordinated Protection Against Fraud, Scams and Financial Crime

    0 shares
    Share 0 Tweet 0
  • DEFSEC TECHNOLOGIES INC. COMMENTS ON NASDAQ NOTIFICATION REGARDING BID PRICE DEFICIENCY AND PROACTIVE STEPS ALREADY TAKEN TO REGAIN AND MAINTAIN COMPLIANCE

    0 shares
    Share 0 Tweet 0
  • PingPong Hits $300 Billion in Annualised Transaction Volume as APAC Surges, and Launches “Currentz” for Banks

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler